首页> 外文期刊>Behavioural Brain Research: An International Journal >Long-lasting effects of fluoxetine and/or exercise augmentation on bio-behavioural markers of depression in pre-pubertal stress sensitive
【24h】

Long-lasting effects of fluoxetine and/or exercise augmentation on bio-behavioural markers of depression in pre-pubertal stress sensitive

机译:氟西汀和/或运动增强对蒲蛋白前抑郁症抑郁生物行为标志物的长持久影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Juvenile depression is of great concern with only limited treatment currently approved. Delayed onset of action, low remission and high relapse rates, and potential long-lasting consequences further complicates treatment and highlights the need for new treatment options. Studies reporting on long-lasting effects of early-life treatment have reported conflicting results, with the pre-adolescent period mostly overlooked. The anti-depressive effect of exercise, as a possible treatment option or augmentation strategy, is dependent on age and exercise intensity. We investigated the immediate (i.e. postnatal day 35 (PND35)) and lasting (PND60 to PND61) effects of pre-pubertal (PND21 to PND34) fluoxetine and/or exercise on bio-behavioural markers of depression and oxidative stress in stress sensitive Flinders Sensitive Line rats. Low, but not moderate, intensity exercise or 5, but not 10, mg/kg/day fluoxetine displayed anti-depressant like properties at PND35. Pre-pubertal treatment with 5 mg/kg/day fluoxetine or low intensity exercise exerted lasting anti-depressive-like effects into adulthood, whereas the combination of these two treatments did not. Furthermore, the combination of fluoxetine plus exercise reduced hippocampal BDNF levels as compared to exercise alone, which may explain the latter findings. In all treatment groups hippocampal SOD activity was significantly increased at PND61, suggesting an increased anti-oxidant capacity in adulthood. In conclusion, the data confirm the anti-depressant-like properties of both early-life fluoxetine and exercise in a genetic animal model of depression. However, optimal lasting effects of early-life interventions may require adjustment of antidepressant dose and/or exercise intensity to developmental age, and that a combination of antidepressant and exercise may not necessarily be augmentative. (C) 2017 Elsevier B.V. All rights reserved.
机译:只有当前批准的有限治疗有限的少年抑郁症是非常关注的。行动延迟,减轻率低和高复发率,以及潜在的长期后果进一步复杂化并突出了对新治疗方案的需求。报告早期治疗的长期效果的研究报告了结果相互矛盾的结果,与前期前期大多忽略了。作为可能的治疗方法或增强策略,运动的抗抑郁作用依赖于年龄和运动强度。我们研究了前期(IE产后第35天(PND35))和持续的(PND60至PND61)对荧光素(PND21至PND34)的荧光素和/或锻炼应激敏感液体敏感抑制和氧化应激的生物行为标志物的影响线大鼠。低,但不适中,强度运动或5,但不是10,Mg / kg /天氟西汀在PND35处显示抗抑郁症状。预普富磷酸盐治疗5毫克/千克/日氟西汀或低强度运动持续持续抗抑郁效果进入成年期,而这两种治疗的组合没有。此外,与单独运动相比,氟西汀加上运动的组合降低了海马BDNF水平,这可以解释后一种结果。在所有治疗组中,PND61,海马SOD活性显着增加,表明成年期抗氧化能力增加。总之,数据证实了早期氟西汀的抗抑郁症状性质和抑制遗传动物模型中的运动。然而,早期干预的最佳持续效果可能需要调节抗抑郁剂剂量和/或运动强度对发育年龄,并且抗抑郁药和运动的组合可能不一定是增强的。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号